- EN
Table TDI-113. All clients entering treatment for opioids by country and type of opioid misused (%), 2011 or most recent year available
| Country | Heroin | Methadone (misuse) | Other opioids (misuse) | Opioids total | Total clients drug known (n) | Total clients drug unknown | |
|---|---|---|---|---|---|---|---|
| Belgium | 28.2 | 2.7 | 1.6 | 36.8 | 5914 | 32 | |
| Bulgaria | 82.0 | 1.9 | 1.1 | 85.0 | 1861 | 117 | |
| Czech Republic | 12.2 | 0.3 | 6.9 | 19.4 | 9217 | 67 | |
| Denmark | 11.1 | 3.7 | 2.8 | 17.5 | 3779 | 1907 | |
| Germany | 0.0 | 0.0 | 0.0 | 44.3 | 70971 | 56 | |
| Estonia | 10.2 | 1.7 | 79.5 | 91.4 | 532 | 0 | |
| Ireland | 1 | 53.8 | 1.6 | 2.5 | 57.9 | 8511 | 0 |
| Greece | 78.5 | 0.3 | 1.9 | 80.6 | 5820 | 14 | |
| Spain | 1 | 32.4 | 1.2 | 0.8 | 34.3 | 53508 | 0 |
| France | 31.5 | 2.0 | 7.2 | 40.7 | 36858 | 10661 | |
| Italy | 2 | 54.4 | 0.5 | 0.4 | 55.3 | 42341 | 15236 |
| Cyprus | 33.9 | 0.0 | 2.8 | 36.7 | 994 | 1 | |
| Latvia | 3 | 40.5 | 1.2 | 11.3 | 52.9 | 1972 | 38 |
| Lithuania | : | : | : | : | 0 | 0 | |
| Luxembourg | 66.1 | 1.3 | 0.0 | 67.4 | 224 | 0 | |
| Hungary | 5.4 | 0.7 | 0.7 | 6.8 | 4783 | 0 | |
| Malta | 78.7 | 0.0 | 0.0 | 78.7 | 1821 | 41 | |
| Netherlands | 9.2 | 2.4 | 1.1 | 12.8 | 13109 | 0 | |
| Austria | 42.1 | 3.3 | 19.1 | 64.5 | 3763 | 800 | |
| Poland | 4 | 45.7 | 0.7 | 1.9 | 48.2 | 1333 | 9 |
| Portugal | 5 | 68.6 | 0.3 | 1.1 | 70.1 | 3764 | 624 |
| Romania | 33.3 | 0.8 | 0.9 | 35.0 | 1853 | 0 | |
| Slovenia | 83.5 | 2.1 | 1.0 | 86.6 | 521 | 0 | |
| Slovakia | 26.1 | 0.1 | 7.5 | 33.7 | 2052 | 261 | |
| Finland | 1.7 | 0.7 | 59.8 | 62.2 | 1443 | 0 | |
| Sweden | 1 | 14.8 | 0.7 | 9.2 | 24.8 | 6223 | 201 |
| United Kingdom | 6 | 51.5 | 4.3 | 3.5 | 59.3 | 114904 | 4748 |
| Croatia | 78.4 | 1.4 | 1.1 | 80.9 | 7665 | 0 | |
| Turkey | 66.0 | 0.0 | 4.3 | 70.3 | 2117 | 0 | |
| Norway | 7 | 0.0 | 0.0 | 0.0 | 32.7 | 8817 | 0 |
| Total | 34.6 | 1.9 | 2.9 | 47.6 | 416670 | 34813 |
Notes:
: Indicates no data are available
'Methadone misuse' is the use of methadone without a medical prescription (see TDI Protocol for further explanations)
Percentages are of clients whose primary drug is known (n).
For more information relative to the treatment centre type, please see Table TDI-7.
(1) Data are from 2010.
(2) In 2011 around 27% of all clients and 32% of new clients were registered as not known / missing for the primary drug category. Caution should be made when comparing data over time.
(3) In 2010 Latvia submitted a new dataset with a more precise TDI EMCDDA definition. Caution should be made when comparing data with previous years.
(4) Data are from 2009. TDI pilot project and Institute of Psychiatry and Neurology (IPiN) system).
(5) In 2010 came into implementation a new national information system implying methodological changes particularly in the registration criteria. Caution should be made when comparing 2010 data with previous years.
(6) Data are from 1st of April 2010 to 31st March 2011.
(7) In Norway the criteria for selecting and grouping cases are main ICD-10 diagnosis codes F11-F16 and F18-F19.
‘General notes for interpreting data'’ on the Explanatory notes and help page.
Source:
Reitox national reports 2012- - TDI